Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
603.58
-2.03 (-0.34%)
May 5, 2025, 4:00 PM EDT - Market closed
Regeneron Pharmaceuticals Employees
Regeneron Pharmaceuticals had 15,106 employees as of December 31, 2024. The number of employees increased by 1,656 or 12.31% compared to the previous year.
Employees
15,106
Change (1Y)
1,656
Growth (1Y)
12.31%
Revenue / Employee
$932,457
Profits / Employee
$297,849
Market Cap
63.78B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 15,106 | 1,656 | 12.31% |
Dec 31, 2023 | 13,450 | 1,599 | 13.49% |
Dec 31, 2022 | 11,851 | 1,483 | 14.30% |
Dec 31, 2021 | 10,368 | 1,245 | 13.65% |
Dec 31, 2020 | 9,123 | 1,023 | 12.63% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
REGN News
- 4 days ago - Regeneron to Highlight Advances at ASCO with Phase 3 Adjuvant Libtayo® (cemiplimab) CSCC Updates and Promising Early Blood Cancer Data with Linvoseltamab Combination - GlobeNewsWire
- 4 days ago - Dupixent® (dupilumab) Data Presented at ATS Reinforce Impact of Targeting Key Type 2 Inflammation Drivers to Improve Outcomes for Chronic Respiratory Diseases - GlobeNewsWire
- 6 days ago - Regeneron Pharma Margins Tighten As Competition Grows, Stock Slides - Benzinga
- 6 days ago - Regeneron Pharmaceuticals, Inc. (REGN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 6 days ago - Top Stock Movers Now: Honeywell, Sherwin-Williams, Regeneron, and More - Investopedia
- 6 days ago - Regeneron Stock Plummets After Earnings Miss - Barrons
- 6 days ago - Regeneron Pharma's first-quarter results miss on lower Eylea demand - Reuters
- 6 days ago - Regeneron Reports First Quarter 2025 Financial and Operating Results - GlobeNewsWire